MedPath

NORTH DALLAS DENTAL HEALTH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)

Completed
Conditions
Determination of Beneficial Effect of Using Enamel Matrix Derivative During Implant Treatment
First Posted Date
2022-06-15
Last Posted Date
2022-06-15
Lead Sponsor
North Dallas Dental Health
Target Recruit Count
34
Registration Number
NCT05419102
Locations
🇺🇸

North Dallas Dental Health, Dallas, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.